WWW.LEXPERT.CA
|
2016
|
LEXPERT 9
Bunting, James (Jim) Davies Ward Phillips & Vine-
berg LLP (416) 367-7433 jbunting@dwpv.com
Mr. Bunting's broad trial practice covers a diverse range of areas, including
corporate commercial disputes, arbitration, advertising and deceptive or
unfair trade practice disputes, franchise disputes, class actions, securities
litigation, defamation and sports-related matters.
Buckley, Timothy O. Borden Ladner Gervais LLP
(416) 367-6169 tbuckley@blg.com
Mr. Buckley is the leader of BLG's Class Action Group. He defends class action
and conventional proceedings related to consumer and product liability, in-
cluding medical devices. Many of the cases pertain to scientific or developing
technology. His case portfolio includes claims from failure of infrastructure,
pharmaceuticals, software, telephone services, medical devices
and consumer products.
Brush, Robert J. Crawley MacKewn Brush LLP
(416) 217-0822 rbrush@cmblaw.ca
Mr. Brush's commercial and securities litigation practice focuses on civil and
regulatory proceedings involving the capital markets, as well as the financial,
insurance and accounting sectors, among others. Due to his specialized
expertise, he has been counsel on a wide range of civil cases, class actions
and regulatory proceedings across the country.
Brown, D. Jeffrey Stikeman Elliott LLP
(613) 564-3472 jbrown@stikeman.com
Mr. Brown is a member of the firm's Competition and Foreign Investment
Group. His practice is comprised mainly of competition law, foreign invest-
ment review and unfair trade practices. He advises clients in respect of
Canadian regulatory aspects of complex mergers and acquisitions and coun-
sels clients with respect to civil and criminal compliance with the Competition
Act and Investment Canada Act.
Brodkin, Andrew Goodmans LLP
(416) 597-4278 abrodkin@goodmans.ca
Mr. Brodkin heads Goodmans's Litigation Group. He focuses on IP litigation,
primarily in pharmaceutical patent disputes. He is particularly active in pro-
ceedings prosecuted pursuant to the Patented Medicines (Notice of Compli-
ance) Regulations. He appears at all levels of courts and has argued
a number of significant patent cases.
Brock, AdE, William Davies Ward Phillips & Vineberg LLP
(514) 841-6438 wbrock@dwpv.com
Litigation partner whose practice is focused on complex commercial, corpo-
rate and securities litigation and arbitration, including relating to mergers
& acquisitions, contractual and shareholders disputes and fraud claims.
Conducts litigation at trial and appellate levels, including before the Supreme
Court of Canada. He has represented Canada's leading companies and gov-
ernment institutions.
"I'm generally a fan of mediation, as it forces
the parties to come to grips with the pros and
cons of their respective positions earlier in the file
than waiting for arbitration or the courthouse,"
says Clarke Hunter, QC, a partner in the Cal-
gary office of Norton Rose Fulbright Canada
LLP. "Even when it doesn't produce a complete
resolution, it oen results in a real focus on what
the real issues are. It can result in more efficien-
cies going forward than if you just head to litiga-
tion with everything still on the table."
Although Cicchetti specializes in arbitration,
she does not think "it's always the best tool in the
box." She says that mediation "should always be
considered" because it's more flexible than arbi-
tration. "Although in arbitration you can pick
and choose the procedural things you need to
get a resolution, you're still talking about a legally
binding process."
Similar to what happens in mediation, a neu-
tral arbitrator — who is acceptable to and paid
for by all the parties — is selected to rule on the
merits of the matter at hand. Unlike mediation,
however, the arbitrator's decision is, with few ex-
ceptions, binding and cannot be appealed. While
LEXPERT-RANKED LAWYERS
